Emmis Acquisition 's Income per employee fell in the second quarter 2026 on a trailing twelve month basis to $ 1,292,730, but the productivity of Emmis Acquisition 's 2 employees remained above the company average.
The Healthcare sector has seen employees of 24 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 216, from total ranking in previous quarter at 218.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EMIS Net Income per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) II. Quarter
Y / Y Net Income Change	-	-83.95 %	-79.29 %	-	-
Net Income per Employee (TTM) $	1,292,730	906,896	3,452,279	5,237,826	2,671,110
EMIS's Total Ranking	# 216	# 218	# 0	# 0	# 0
Seq. Net Income Change	-23.05 %	4.32 %	-	-	-

EMIS Company Profile >> Back to EMIS Efficiency Comparisons >> Compare EMIS Net Income per Employee to its Competitors

EMIS Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 25
Healthcare Sector	# 32
Overall Market	# 216

Net Income per Employee Statistics
High	Average	Low
$ 26,307,000	$ -1,689,725	$ -27,495,000
(Jun 30 2014)		(Mar 31 2015)

Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector	Income per Employee	Income 12 month ending Jun 30 2026	Number of Employees Jun 30 2026
Innoviva Inc	2,246,767.30	$ 357.236 Million	159
Quince Therapeutics Inc	2,060,342.11	$ 78.293 Million	38
Fortress Biotech Inc	2,030,307.69	$ 158.364 Million	78
Pulmatrix Inc	1,998,500.00	$ 3.997 Million	2
Elutia Inc	1,992,615.38	$ 51.808 Million	26
Rigel Pharmaceuticals Inc	1,850,051.72	$ 321.909 Million	174
Exelixis Inc	1,653,085.44	$ 1,896.089 Million	1,147
Actinium Pharmaceuticals Inc	1,514,120.00	$ 37.853 Million	25
Q32 Bio Inc	1,407,750.00	$ 33.786 Million	24
Ironwood Pharmaceuticals inc	1,298,680.00	$ 129.868 Million	100
Agenus Inc	1,135,037.04	$ 91.938 Million	81
Tg Therapeutics Inc	1,106,491.23	$ 441.490 Million	399
Halozyme Therapeutics Inc	977,768.32	$ 413.596 Million	423
Zevra Therapeutics Inc	949,245.90	$ 57.904 Million	61
United Therapeutics Corporation	936,357.14	$ 1,310.900 Million	1,400
Protagenic Therapeutics Inc new	910,314.00	$ 5.462 Million	6
Elite Pharmaceuticals Inc	871,814.86	$ 56.668 Million	65
Krystal Biotech Inc	818,525.42	$ 241.465 Million	295
The Greater Cannabis Company Inc	740,754.00	$ 0.741 Million	1
Omeros Corporation	713,291.43	$ 124.826 Million	175
Prestige Consumer Healthcare Inc	712,757.89	$ 406.272 Million	570
Amgen Inc	672,538.46	$ 8,743.000 Million	13,000
Atlantic Coastal Acquisition Corp Ii	670,333.33	$ 2.011 Million	3

Date modified: 2026-09-03T03:00:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.